Olanzapine
Generic Name: Olanzapine
Uses & Medical Indications
Treatment of schizophrenia, bipolar I disorder, treatment-resistant depression (with fluoxetine)
Schizophrenia, Bipolar Mania, Agitation
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
Olanzapine works at the cellular level to correct underlying biochemical imbalances, reduce clinical symptoms, and support overall health.
Clinical Mechanism of Action (MoA)
Olanzapine exerts targeted therapeutic activity by interacting with specific cellular receptors, enzymatic pathways, or biological signaling cascades to relieve symptoms and restore physiological balance.
Dosage & Administration Guidelines
5-10 mg initially, up to 20 mg daily
2.5-5 mg initially for adolescents (13-17 yrs)
Start at 2.5-5 mg daily
20 mg/day
No adjustment necessary
Start at lower dose (5 mg) and use caution
Side Effects & Safety Warnings
Weight gain, somnolence, increased appetite, dry mouth, dizziness
Tardive dyskinesia, neuroleptic malignant syndrome, hyperglycemia, hyperlipidemia
Hypersensitivity to olanzapine
Increased mortality in elderly patients with dementia-related psychosis
Interactions (Drugs, Food & Alcohol)
CNS depressants, antihypertensives, levodopa, CYP1A2 inducers/inhibitors (fluvoxamine, smoking)
N/A
Increases CNS depression
Pregnancy & Breastfeeding Safety
Risk of extrapyramidal and/or withdrawal symptoms in neonates
Excreted in human milk; use caution or avoid
Patient Counseling & Practical Advice
May cause weight gain; monitor diet. Do not abruptly stop taking. Avoid alcohol.
Take as soon as remembered. Skip if near next dose.
Weight, lipid panel, fasting blood glucose, AIMS (for tardive dyskinesia)
Related Medicines in Atypical Antipsychotics
When to Seek Urgent Medical Attention
Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.
Content for Olanzapine was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
- World Health Organization (WHO) — Model List of Essential Medicines
- Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
- National Health Service (NHS) — Medicines A to Z Clinical Guidelines
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.